Healthpeak Properties, Inc. $DOC Stake Raised by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI raised its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 61.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,280 shares of the real estate investment trust’s stock after acquiring an additional 25,935 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Healthpeak Properties were worth $1,122,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in DOC. State Street Corp lifted its position in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. grew its position in Healthpeak Properties by 8.6% during the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after purchasing an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its position in Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC increased its stake in Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after buying an additional 123,274 shares during the period. Finally, Invesco Ltd. increased its stake in Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after buying an additional 1,648,012 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.23% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on DOC. Evercore lowered shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price for the company. in a research note on Monday, May 11th. BMO Capital Markets upped their price target on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 15th. Raymond James Financial started coverage on Healthpeak Properties in a report on Wednesday, June 17th. They set a “market perform” rating for the company. Wells Fargo & Company lifted their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 15th. Finally, Mizuho boosted their target price on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, July 6th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.62.

Healthpeak Properties Price Performance

NYSE DOC opened at $22.59 on Wednesday. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $15.58 billion, a PE ratio of 70.61, a price-to-earnings-growth ratio of 3.46 and a beta of 1.02. The company has a 50 day moving average price of $20.57 and a two-hundred day moving average price of $18.34. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.72.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same period in the previous year, the firm posted $0.46 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.4%. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.